AZN · AstraZeneca PLC
121.10
GBPUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
GBP189.85B
PE
N/A
EV/EBITDA
N/A
DIV Yield
N/A
Payout Ratio
N/A
MQV Rating
4Weak
As at 24/08/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- All-Consensus
- ALL-Recommendations
- Consensus Cheap
- Engulfing Bullish
- HALO 100
- HALO 200
- HALO 50
- HALO All
- HALO Capital Efficiency
Key Fundamentals
EPS 3 yr Growth
N/A
EBITDA Margin
N/A
Operating Cashflow
N/A
Free Cash Flow Return
N/A
ROIC
N/A
Interest Coverage
N/A
Quick Ratio
N/A
Performance
52 weeks range
N/A
Trade Value (12mth)
N/A
1 week
%
1 month
%
YTD
%
1 year
%
All time high
N/A
Additional Data
Shares Outstanding (Fully Diluted)
N/A
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
N/A
Short Sell (% of issue)
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Very Strong
Halo Model
Mqv
Weak
Garp
Neutral
Mqv Small
Neutral
Momentum
Price
Very Weak
Earnings
Neutral
Growth
Earnings
Weak
Dividends
Neutral
Quality
Capital Efficiency
Very Strong
Balance Sheet
Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
19 August 26RNS | |
17 August 26RNS | |
17 August 26RNS | |
17 August 26RNS | |
04 August 26RNS |
Key Stakeholders
| Name | Title |
| Investor AB (Investment Company) | Operating Division |
| OrbiMed Advisors Private Equity | Subsidiary |
| Pascal Soriot | Individual |
| Aradhana Sarin | Individual |
| Parkwood LLC | Private Company |
